20-Nov-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Biology
Pharmacology & D...
Neuropharmacolog...
Browse
ALL OF BIOLOGY
Pharmacology & Drug Discovery
Antimicrobial Agents
Cancer Therapeutics
Cardiovascular Pharmacology
Drug Discovery & Design
Endocrine & Metabolic Pharmacology
Gastrointestinal Pharmacology
Genito-Urinary & Reproductive Pharmacology
Immunopharmacology & Hematologic Pharmacology
Molecular Pharmacology
Musculoskeletal & Dermatologic Pharmacology
Neuropharmacology & Psychopharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Renal Pharmacology
Respiratory Pharmacology
Toxicology
Related Sections
Bioinformatics
Biomacromolecule-Ligand Interactions
Cell Signalling
Cell Signalling & Trafficking Structures
Chemical Biology of the Cell
Directed Molecular Evolution
Genomics
Macromolecular Chemistry
Medical Genetics
Physiogenomics
Protein Chemistry & Proteomics
Small Molecule Chemistry
selected for
My F1000 Biology
Browse > Pharmacology & Drug Discovery > Neuropharmacology & Psychopharmacology
Top 10
/
All time Top 10
/
Most viewed
/
Hidden jewels
Page 1 of 28. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
confirmations
controversial
dissenting
drug target
hypotheses
new findings
refutation
tech advances
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Must Read
F1000 Factor
6.0
Confirmation
Hypothesis
New Finding
Novel Drug Target
Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal.
Surget A, Saxe M, …, Hen R, Belzung C
Biol Psychiatry
2008 Aug 15
64
(4):293-301 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Esther Sternberg with Marni Silverman
Evaluated 17 Nov 2008
Recommended
F1000 Factor
3.0
Hypothesis
New Finding
Neural circuitry of stress-induced insomnia in rats.
Cano G, Mochizuki T, Saper CB
J Neurosci
2008 Oct 1
28
(40):10167-84 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Luis de Lecea
Evaluated 17 Nov 2008
Must Read
F1000 Factor
6.0
New Finding
Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase.
Behrens MM, Ali SS, …, Quick KL, Dugan LL
Science
2007 Dec 7
318
(5856):1645-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Emery Brown
Evaluated 17 Nov 2008
Must Read
F1000 Factor
6.0
New Finding
Novel Drug Target
Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.
Du H, Guo L, …, Chen JX, Yan SD
Nat Med
2008 Oct
14
(10):1097-105 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Heinz Osiewacz
Evaluated 14 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
PirB is a functional receptor for myelin inhibitors of axonal regeneration.
Atwal JK, Pinkston-Gosse J, …, Shatz C, Tessier-Lavigne M
Science
2008 Nov 7
322
(5903):967-70 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Susan K. McConnell
Evaluated 14 Nov 2008
Recommended
F1000 Factor
3.0
Hypothesis
Controversial
Novel Drug Target
Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression.
Ghia JE, Blennerhassett P, Collins SM
J Clin Invest
2008 Jun
118
(6):2209-18 [
abstract on PubMed
] [
related articles
] [
FREE full text
]
Selected by
| Ruud Buijs
Evaluated 14 Nov 2008
Exceptional
F1000 Factor
9.0
New Finding
Controversial
Refutation
Increased cognitive functioning in symptomatic Huntington's disease as revealed by behavioral and event-related potential indices of auditory sensory memory and attention.
Beste C, Saft C, Güntürkün O, Falkenstein M
J Neurosci
2008 Nov 5
28
(45):11695-702 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jerry Buccafusco
Evaluated 12 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
Discovery of 1,4-substituted piperidines as potent and selective inhibitors of T-type calcium channels.
Yang ZQ, Barrow JC, …, Koblan KS, Renger JJ
J Med Chem
2008 Oct 23
51
(20):6471-7 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| David Triggle
Evaluated 12 Nov 2008
Recommended
F1000 Factor
3.0
Confirmation
Hypothesis
New Finding
Blocking central opiate function modulates hedonic impact and anterior cingulate response to rewards and losses.
Petrovic P, Pleger B, …, Critchley H, Dolan RJ
J Neurosci
2008 Oct 15
28
(42):10509-16 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Kent Berridge
Evaluated 10 Nov 2008
Recommended
F1000 Factor
3.0
New Finding
Novel Drug Target
Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.
Desroches J, Guindon J, Lambert C, Beaulieu P
Br J Pharmacol
2008 Aug 11 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Roger Pertwee with Maria-Grazia Cascio
Evaluated 10 Nov 2008
top of page
Page 1 of 28. Select Page:
1
2
3
4
5
6
7
8
9
10
>>
Display
10
/
20
/
50
papers per page
© 1999-2008 Biology Reports Ltd unless otherwise stated.
< info@f1000.com >
Terms and conditions
Legal info